Shared Decision-Making: AFib 2gether Mobile App
Completed · Not applicable
Conditions studied: Atrial Fibrillation New Onset
In brief
Shared Decision-Making: AFib 2gether™ is a research study that focuses on a mobile application developed by Pfizer, Inc with consultation from Dr McManus' called AFib 2gether™. Through this app, patients can determine their risk of stroke due to atrial fibrillation and prioritize questions and concerns for discussion with their cardiology provider.
Key facts
- Study ID
- NCT04118270
- Run by
- University of Massachusetts, Worcester
- People needed
- 50
- Starts
- 2019-11-01
- Expected to finish
- 2020-06-26
- Last updated by the study team
- 2022-05-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Providers:
- Caring for at least 3 patients aged 18 years and older
- Have at least 3 patients with International Classification of Diseases tenth revision (ICD-10) diagnostic code consistent with atrial fibrillation (AF) or atrial flutter
- Have at least 3 patients with a CHA2DS2-VASc stroke risk score of 2 or more
- Have at least 3 patients who are not on anticoagulation
- Have at least 3 patients with upcoming appointments within the next 4 months
- Patients:
- Age 18+
- Preferred language is English
- Atrial fibrillation diagnosis
- Chads vasc score 2 or higher
- Not on anticoagulants
- No watchman or atrial appendage closure
- Had an ambulatory care center (ACC) cardiology appointment in the past 12 months
- Future appointment in the next 4 months with the same provider
You may not qualify if…
- Providers:
- Providers who do not care for at least 3 patients aged 18 years and older
- Have patients that do not have an ICD-10 diagnostic code consistent with AF or atrial flutter
- Does not have patients with a CHA2DS2-VASc stroke risk score of 2 or more
- Their patients are on anticoagulation
- Their 3 patients do not have an upcoming visit within the next 4 months
- Patients:
- Under the age of 18; patients
- No ICD-10 diagnostic code consistent with AF or atrial flutter
- Did not have a visit with a cardiovascular medicine specialist in the previous one year
- Patients with a CHA2DS2-VASc score less than 2
- Currently prescribed an anticoagulant
- No upcoming cardiology visit in the next 3 months
- Has a WATCHMAN device or left atrial appendage closure surgery
- On hospice or for whom life expectancy is less than six months and patients
- Bleeding episode or fall with injury in the last four weeks
- Does not speak English
- Prisoner
Where it is running
- UMass Medical School — Worcester, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.